Protein kinase C alpha, Protein kinase C beta, Protein kinase C theta (PKCα, PKCβ, PKCθ)

Protein kinase C alpha, beta, and theta are isoforms of the protein kinase C (PKC) family, which are serine/threonine protein kinases involved in a wide range of cellular signaling processes. PKC enzymes are activated by diacylglycerol (DAG) and, for conventional isoforms (including PKCα and PKCβ), by Ca²⁺ ions, while novel isoforms (including PKCθ) are not dependent on Ca²⁺. All PKCs possess a regulatory domain (containing C1 and C2 domains) and a catalytic domain, which together control activation and substrate phosphorylation. These isoforms regulate essential processes such as cell proliferation, apoptosis, immune cell activation, and are implicated in the pathogenesis of cancer, cardiovascular disorders, autoimmune diseases, and neurodegeneration. PKCθ is especially important in T cell activation and immune response. Selective inhibitors and modulators are in development for various therapeutic indications, but high sequence conservation among PKC family members presents challenges for achieving specificity and avoiding side effects.

Other names

PKC alpha (PKCα)PKC beta (PKCβ)PKC theta (PKCθ)Protein kinase C isoforms α, β, θSerine/threonine-protein kinase C alpha/beta/theta

ATP-competitive inhibition of kinase activity; Allosteric modulation; Competitive inhibition at substrate or cofactor (DAG, Ca²⁺) binding domains; Activation by phorbol ester analogs (mimicking DAG)